Clinical Trial Update: Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety and efficacy of adjunctive levetiracetam in female subjects with catamenial epilepsy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 4 | Status: COMPLETED